← Back to Universal Health Realty Income Trust
Stoqly stoqly.net Company report Β· October 27, 2026

Universal Health Realty Income Trust

UHT NYSEΒ· Real Estate Investment Trusts

Last close Β· Oct 23, 2026

$37.67

KIRA Β· Stoqly’s AI analyst, in plain words

  • Universal Health Realty Income Trust had $99.2M of revenue in fiscal 2025, up 0.2% on the year before. Over five years, revenue changed +4.9% a year on average.
  • Its operating margin was 35.0%, down 2.1Β pts: of every 100 in sales, about 35 is left after running the business.
  • Universal Health Realty Income Trust made $17.6M of net profit in fiscal 2025. From fiscal 2016 to 2025, diluted EPS grew βˆ’0.1% a year.
  • Universal Health Realty Income Trust returned $41.0M to shareholders in fiscal 2025. The diluted share count rose 0.2%.
  • Universal Health Realty Income Trust owes $368M more than it holds in cash, about 5.8 years of operating profit.

Market cap

$523M

P/E

26.9x

Revenue

$99.2M

Net income

$17.6M

Free cash flow

β€”

Operating margin

35.0%

Universal Health Realty Income Trust in 30 seconds Β· fiscal 2025

So-so

Are sales growing?

+0.2%

Only a little. Sales grew 0.2% last year.

Good

Does it make a profit?

17.8%

Yes. It keeps 17.8% of every sale as profit.

Weak

Is debt under control?

5.8x

Heavy. Repaying its debt would take 5.8 years of operating profit.

So-so

How healthy are the accounts?

4 / 7

Mixed. It passes 4 of 7 health tests.

For information

How is the share priced?

26.9x

One share costs 26.9 times its yearly profit per share.

What Universal Health Realty Income Trust does

No business description yet.

Fiscal year ends
December 31, 2025
Latest annual report
10-K Β· Feb 25, 2026
Legal name
UNIVERSAL HEALTH REALTY INCOME TRUST
CIK
0000798783
stoqly.net Β· UHT Β· Generated October 27, 2026 Not investment advice Β· Page 1 of 3
Stoqly stoqly.net Company report Β· October 27, 2026

Universal Health Realty Income Trust Β· UHT

Results and finances

The last 5 fiscal years. Amounts in USD.

Fiscal yearFY21FY22FY23FY24FY25
Sales and profit
Revenue $84.2M $90.6M $95.6M $99.0M $99.2M
Revenue growth 7.9% 7.6% 5.5% 3.6% 0.2%
Net interest income βˆ’$8.8M βˆ’$10.8M βˆ’$16.9M βˆ’$18.8M βˆ’$18.9M
Operating margin 34.3% 33.8% 32.8% 37.2% 35.0%
Net income $109M $21.1M $15.4M $19.2M $17.6M
Net margin 129.7% 23.3% 16.1% 19.4% 17.8%
Diluted EPS $7.92 $1.53 $1.11 $1.39 $1.27
Cash
Cash from operations $47.7M $46.8M $42.9M $46.9M $49.1M
Capital expenditure $13.0M $13.6M $7.6M β€” β€”
Free cash flow $34.7M $33.2M $35.3M β€” β€”
FCF margin 41.3% 36.6% 37.0% β€” β€”
Dividends paid $38.5M $39.2M $39.8M $40.4M $41.0M
Share count change 0.1% 0.1% 0.1% 0.2% 0.2%
Debt and strength
Cash and short-term investments $22.5M $7.6M $8.2M $7.1M $6.7M
Debt incl. finance leases $329M $343M $360M $368M $375M
Shareholders' equity $235M $229M $201M $180M $152M
Net debt / EBITDA 5.4x 5.9x 5.9x 5.6x 5.8x
Returns and quality
Return on capital 4.2% 4.3% 4.5% 5.4% 5.3%
Return on equity 55.4% 9.1% 7.2% 10.1% 10.6%
Return on tangible equity 48.4% 9.6% 8.0% 11.2% 12.0%
Piotroski F-score 4 4 4 5 4

Insiders bought, 12 months

$0.5M

1 insider

Insiders sold, 12 months

$0.0M

0 insiders

Of sales under plans

β€”

$0.0M

How to read these numbers

Revenue:
Total sales reported in the income statement.
Operating margin:
Operating income as a share of revenue.
Net income:
Profit after all expenses, interest and tax.
Free cash flow:
Cash from operations minus capital spending.
Net debt / EBITDA:
Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
Return on capital:
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
stoqly.net Β· UHT Β· Generated October 27, 2026 Not investment advice Β· Page 2 of 3
Stoqly stoqly.net Company report Β· October 27, 2026

Universal Health Realty Income Trust Β· UHT

Charts and comparison

Ten years at a glance, and how it stacks up against similar companies.

Revenue

Net income

Margins, % of revenue

Gross Operating Net

Cash vs debt (incl. leases)

Cash Debt

Free cash flow

Dividends and buybacks

Dividends Buybacks

KIRA

At $37.67 a share, the company is worth $523M: 26.9 times its earnings of the last four quarters.

Source: SEC EDGAR XBRL filings (CIK 0000798783). Data updated October 24, 2026. For information only β€” not investment advice. Check the original filings before relying on any figure.